Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma M Yamauchi, R Yamaguchi, A Nakata, T Kohno, M Nagasaki, ... Public Library of Science 7 (9), e43923, 2012 | 163 | 2012 |
A comparative study of statistical methods used to identify dependencies between gene expression signals S de Siqueira Santos, DY Takahashi, A Nakata, A Fujita Briefings in bioinformatics 15 (6), 906-918, 2014 | 162 | 2014 |
A novel serum 4-microRNA signature for lung cancer detection E Nadal, A Truini, A Nakata, J Lin, RM Reddy, AC Chang, N Ramnath, ... Scientific reports 5 (1), 12464, 2015 | 140 | 2015 |
Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord AT Guy, Y Nagatsuka, N Ooashi, M Inoue, A Nakata, P Greimel, A Inoue, ... Science 349 (6251), 974-977, 2015 | 129 | 2015 |
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2 T Nishimura, A Nakata, X Chen, K Nishi, M Meguro-Horike, S Sasaki, ... Oncogene 38 (14), 2464-2481, 2019 | 90 | 2019 |
Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell–like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit T Murayama, T Nakaoku, M Enari, T Nishimura, K Tominaga, A Nakata, ... Cancer research 76 (4), 974-983, 2016 | 71 | 2016 |
Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs A Nakata, R Yoshida, R Yamaguchi, M Yamauchi, Y Tamada, A Fujita, ... Scientific reports 5 (1), 13076, 2015 | 49 | 2015 |
Domain–domain interaction of P-Rex1 is essential for the activation and inhibition by G protein βγ subunits and PKA D Urano, A Nakata, N Mizuno, K Tago, H Itoh Cellular signalling 20 (8), 1545-1554, 2008 | 49 | 2008 |
G‐protein signalling negatively regulates the stability of aryl hydrocarbon receptor A Nakata, D Urano, Y Fujii‐Kuriyama, N Mizuno, K Tago, H Itoh EMBO reports 10 (6), 622-628, 2009 | 42 | 2009 |
Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer A Nakata, N Gotoh Expert opinion on therapeutic targets 16 (8), 771-781, 2012 | 38 | 2012 |
MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells T Murayama, Y Takeuchi, K Yamawaki, T Natsume, M Li, RCN Marcela, ... Cancer science 112 (3), 1209-1224, 2021 | 23 | 2021 |
Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer F Andrade, A Nakata, N Gotoh, A Fujita Genetics and molecular biology 43, e20180269, 2020 | 20 | 2020 |
MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma R Yiming, Y Takeuchi, T Nishimura, M Li, Y Wang, M Meguro‐Horike, ... Cancer Science 112 (9), 3810-3821, 2021 | 17 | 2021 |
A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015; 5: 12464 E Nadal, A Truini, A Nakata, J Lin, RM Reddy, AC Chang, N Ramnath, ... | 4 | |
Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties H Makita, K Endo, Y Kasahara, A Nakata, M Moriyama-Kita, K Ishikawa, ... Oncology Letters 21 (5), 385, 2021 | 3 | 2021 |
Drug-resistance and cancer stem-like properties dependent on the mitochondrial metabolic enzyme T Nishimura, A Nakata, S Kohno, C Takahashi, T Soga, A Tojo, N Gotoh CANCER SCIENCE 109, 273-273, 2018 | 1 | 2018 |
Regenerative Therapy M Konno, H Ishii, J Koseki, N Tanuma, N Nishida, K Kawamoto, ... development 5, 6, 2015 | 1 | 2015 |
A model-based clustering algorithm with covariates adjustment and its application to lung cancer stratification. CEM Relvas, A Nakata, G Chen, DG Beer, N Gotoh, A Fujita Journal of bioinformatics and computational biology, 2350019-2350019, 2023 | | 2023 |
Cancer Stem-like traits are up-regulated in gefitinib-resistant lung cancer cells Y Reheman, Y Takeuchi, T Nishimura, A Nakata, N Gotoh CANCER SCIENCE 112, 697-697, 2021 | | 2021 |
Cancer stem-like properties and drug resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2 N Gotoh, T Nishimura, A Nakata, S Horike, S Kohno, C Takahashi, T Soga, ... Cancer Research 78 (13_Supplement), 168-168, 2018 | | 2018 |